A recombinant macrophage infectivity potentiator (rMIP) proteins of induces significant serum bactericidal antibody production in mice and is a candidate meningococcal vaccine antigen. showed bactericidal activity against homologous type I MIP (median titers of 128 to 256) and heterologous type II and III (median titers of 256 to 512) strains, thereby providing at least 82%… Continue reading A recombinant macrophage infectivity potentiator (rMIP) proteins of induces significant serum